TRAUMATIC BRAIN INJURY CLINICAL TRIAL OPENS AT JUPITER MEDICAL CENTER

May 6, 2013

FOR IMMEDIATE RELEASE

JUPITER, Fla. (May 6, 2013) – Jupiter Medical Center’s Clinical Research Department has opened a new clinical trial for traumatic brain injury patients, under the leadership of Barry Miskin, MD, Chief of Surgery and Medical Director of Wound Care and Hyperbarics.

Traumatic Brain Injury (TBI) is a major cause of death and disability worldwide. Even when treated early with current medical therapy, there is a minimal chance for recovery. TBI causes symptoms such as headache, nausea, balance problems, numbness and tingling, difficulty concentrating, drowsiness and even death. Ischemia (inadequate blood supply) has been implicated as a major cause of symptoms, disabilities from TBI and secondary brain injury. Without oxygen, the brain cannot heal and symptoms cannot improve.

The Wound Healing & Hyperbaric Center at Jupiter Medical Center takes a multi-disciplinary approach to healing complex wounds. Hyperbaric Oxygen (HBO) treatment of diabetic wounds and foot ulcers stimulates the healing process by oxygenating an area that was not accessible before - thus preventing healing.

Under the guidance of the Food and Drug Administration (FDA), the new clinical trial will test the use of HBO to determine if oxygenation can stimulate the healing process of brain injuries. Patients will receive 40 to 120 HBO treatments contingent upon their progress. Each patient will undergo 5 times-a-week HBO treatments to 1.5 ATA (atmospheres absolute).  Progress is determined based on blood flow results from a Single Photon Emission Computed Tomography (SPECT) scan and cognitive tests.  To be eligible for the trial, patients must be diagnosed with brain injury as demonstrated by loss of consciousness due to the injury that is a minimum of 1 year old.

Researchers at Jupiter Medical Center anticipate that using this data will develop better treatments and tests that are more tailored, or individualized, than current treatments for patients with TBI. The overall goals of this clinical trial are a decrease in symptoms, improved cerebral blood flow and neurological improvement in patients with TBI.

“The TBI clinical trial is a way to determine if hyperbaric oxygenation is a leading-edge treatment option available for brain injury patients,” said Dr. Miskin. “We are thrilled to be able to offer this trial to our community.”

If you are interested in participating in this trial, or for more information, please contact Jeanine Secor, RN, BSN, CCRP, clinical research manager, at (561) 263-5791.

About Jupiter Medical Center
A not-for-profit 283-bed regional medical center consisting of 163 private acute care hospital beds and 120 long-term care, sub-acute rehabilitation and Hospice beds, Jupiter Medical Center provides a broad range of services with specialty concentrations in oncology, imaging, orthopedics & spine, digestive health, emergency services, lung & thoracic, women’s health, weight management and men’s health. Founded in 1979, the Medical Center has approximately 1,500 team members, 520 physicians and 700 volunteers. Jupiter Medical Center is the recipient of the HealthGrades ‘America’s 50 Best’ Award™ for three years in a row (2011-2013) and the Distinguished Hospital Award - Clinical Excellence™ for nine years in a row (2005-2013). For more information on Jupiter Medical Center, please call (561) 263-2234 or visit www.jupitermed.com.

# # #

 

Press Releases- PR 2013